Cargando…
Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer
PURPOSE: Current management for patients with differentiated thyroid cancer includes near total thyroidectomy and radioactive iodine therapy followed by administration of supraphysiological doses of levothyroxine (L-T4). Although hyperthyroidism is a well known risk factor for osteoporosis, the effe...
Autores principales: | Lee, Mi Young, Park, Jae Hyun, Bae, Keum Seok, Jee, Yong Gwan, Ko, An Na, Han, Yong Jea, Shin, Jang Yel, Lim, Jung Soo, Chung, Choon Hee, Kang, Seong Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Surgical Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994597/ https://www.ncbi.nlm.nih.gov/pubmed/24761409 http://dx.doi.org/10.4174/astr.2014.86.2.55 |
Ejemplares similares
-
Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma
por: Kim, Chei Won, et al.
Publicado: (2015) -
Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
por: Zanella, André Borsatto, et al.
Publicado: (2022) -
Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023) -
Bone turnover in elderly men: relationships to change in bone mineral density
por: Nguyen, Tuan V, et al.
Publicado: (2007) -
Bone turnover markers in serum but not in saliva correlate with bone mineral density
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2020)